Alan Mackay - Concepedia

Author

Alan Mackay

Also Known As

A G Mackay, A MacKay, A Mackay, A. G. Mackay, A. MacKay, A. Mackay, A.G. Mackay, AG Mackay, ALAN G. MACKAY, Alan G. Mackay

489

Publications

19.5K

Citations

H-Index

116

Concepts

All Affiliations

Institute of Cancer Research Breast Cancer Now University College London Breast Cancer Research Foundation Royal Marsden Hospital

About

Alan Mackay is an author at Institute of Cancer Research specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	56	9K
2	Health Sciences	10	10	1.6K
3	Engineering	6	6	1.3K
4	Natural Sciences	6	6	506
5	Social Sciences	1	1	215

Alan Mackay

140

Publications

18.1K

Citations

H-Index

Page 1

	Year	Citations
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Dominik Sturm, Brent A. Orr, Umut H. Toprak, Cell Neuro-oncologyMolecular ClassificationCerebral OrganoidNeurologyNeuroscience	2016	973
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells Gemma Molyneux, Felipe C. Geyer, Fiona‐Ann Magnay, Cell stem cell Lineage PlasticityBreast OncologyDevelopmental BiologyMedicineBreast Cancer	2010	800
<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer Nicholas C. Turner, Alex Pearson, Rachel Sharpe, Cancer Research Endocrine OncologyBreast OncologyEndocrine-related CancerMedicineCancer Cell Biology	2010	712
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations Pawel Buczkowicz, Christine M. Hoeman, Patricia Rakopoulos, Nature Genetics Neuro-oncologyRadiation OncologyEngineeringTumor HeterogeneityMedicine	2014	643
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes David Castel, Cathy Philippe, Raphaël Calmon, Acta Neuropathologica Hist1h3b K27m MutationsPathologyHigh-grade GliomasDiffuse Midline GliomaHistone H3f3a	2015	642
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma Kathryn R. Taylor, Alan Mackay, Nathalène Truffaux, Nature Genetics Neuro-oncologySomatic VariantTumor HeterogeneityPathologyAcvr1 Mutations	2014	514
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets Nicholas C. Turner, Maryou B. Lambros, Hugo M. Horlings, Oncogene Breast OncologyFunctional GenomicsPotential Therapeutic TargetsEngineeringMedicine	2010	405
Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation Nobuyuki Udagawa, Nicole J. Horwood, Jan Elliott, The Journal of Experimental Medicine	1997	375
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation Felipe C. Geyer, Magali Lacroix‐Triki, Kay Savage, Modern Pathology Transcriptional RegulationRadiation OncologyOncologyBreast OncologyMedicine	2010	371
Breast cancer molecular profiling with single sample predictors: a retrospective analysis Britta Weigelt, Alan Mackay, Roger A’Hern, The Lancet Oncology	2010	359

Page 1